p.76 抽出テキスト
197. Karayiannides S, Norhammar A, Landstedt-Hallin L, Friberg L, Lundman P. Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study. Eur J Prev Cardiol 2022;29:1759–69. https:// doi.org/10.1093/eurjpc/zwac093 198. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010;137: 263–72. https://doi.org/10.1378/chest.09-1584 199. Abdel-Qadir H, Gunn M, Lega IC, Pang A, Austin PC, Singh SM, et al. Association of diabetes duration and glycemic control with stroke rate in patients with atrial fibrillation and diabetes: a population-based cohort study. J Am Heart Assoc 2022;11: e023643. https://doi.org/10.1161/JAHA.121.023643 200. Donnellan E, Aagaard P, Kanj M, Jaber W, Elshazly M, Hoosien M, et al. Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation. JACC Clin Electrophysiol 2019;5:897–903. https:// doi.org/10.1016/j.jacep.2019.05.018 201. D’Souza S, Elshazly MB, Dargham SR, Donnellan E, Asaad N, Hayat S, et al. Atrial fibrillation catheter ablation complications in obese and diabetic patients: insights from the US nationwide inpatient sample 2005–2013. Clin Cardiol 2021;44:1151–60. https://doi.org/10.1002/clc.23667 202. Creta A, Providencia R, Adragao P, de Asmundis C, Chun J, Chierchia G, et al. Impact of type-2 diabetes mellitus on the outcomes of catheter ablation of atrial fibrillation (European Observational Multicentre Study). Am J Cardiol 2020;125:901–6. https:// doi.org/10.1016/j.amjcard.2019.12.037 203. Wang Z, Wang YJ, Liu ZY, Li Q, Kong YW, Chen YW, et al. Effect of insulin resistance on recurrence after radiofrequency catheter ablation in patients with atrial fibrillation. Cardiovasc Drugs Ther 2023;37:705–13. https://doi.org/10.1007/s10557-022-07317-z 204. Papazoglou AS, Kartas A, Moysidis DV, Tsagkaris C, Papadakos SP, Bekiaridou A, et al. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation. Cardiovasc Diabetol 2022;21:39. https://doi.org/10.1186/s12933-022-01473-0 205. Zhang Z, Zhang X, Korantzopoulos P, Letsas KP, Tse G, Gong M, et al. Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis. BMC Cardiovasc Disord 2017;17:96. https://doi.org/10.1186/s12872-017-0531-4 206. Bell DSH, Goncalves E. Atrial fibrillation and type 2 diabetes: prevalence, etiology, pathophysiology and effect of anti-diabetic therapies. Diabetes Obes Metab 2019;21: 210–7. https://doi.org/10.1111/dom.13512 207. Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J 2023;44:4043–140. https://doi.org/10.1093/eurheartj/ehad192 208. Di Benedetto L, Michels G, Luben R, Khaw KT, Pfister R. Individual and combined impact of lifestyle factors on atrial fibrillation in apparently healthy men and women: the EPIC-Norfolk prospective population study. Eur J Prev Cardiol 2018;25:1374–83. https://doi.org/10.1177/2047487318782379 209. Grundvold I, Bodegard J, Nilsson PM, Svennblad B, Johansson G, Ostgren CJ, et al. Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study. Cardiovasc Diabetol 2015;14:5. https://doi.org/10.1186/ s12933-014-0170-3 210. Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M, et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol 2015;1:139–52. https://doi. org/10.1016/j.jacep.2015.04.004 211. Providencia R, Adragao P, de Asmundis C, Chun J, Chierchia G, Defaye P, et al. Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study. J Am Heart Assoc 2019;8:e012253. https:// doi.org/10.1161/JAHA.119.012253 212. Glover BM, Hong KL, Dagres N, Arbelo E, Laroche C, Riahi S, et al. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation. Heart 2019; 105:244–50. https://doi.org/10.1136/heartjnl-2018-313490 213. Gessler N, Willems S, Steven D, Aberle J, Akbulak RO, Gosau N, et al. Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial. Europace 2021;23:1548–58. https://doi.org/10.1093/europace/euab122 214. Mohanty S, Mohanty P, Natale V, Trivedi C, Gianni C, Burkhardt JD, et al. Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation. J Cardiovasc Electrophysiol 2018;29:246–53. https://doi.org/10.1111/jce. 13394 215. Donnellan E, Wazni OM, Kanj M, Elshazly M, Hussein AA, Patel DR, et al. Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol 2020;31:1979–86. https://doi.org/10.1111/jce.14607 216. Donnellan E, Wazni OM, Kanj M, Baranowski B, Cremer P, Harb S, et al. Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. Europace 2019;21:1476–83. https:// doi.org/10.1093/europace/euz183 217. Donnellan E, Wazni O, Kanj M, Hussein A, Baranowski B, Lindsay B, et al. Outcomes of atrial fibrillation ablation in morbidly obese patients following bariatric surgery compared with a nonobese cohort. Circ Arrhythm Electrophysiol 2019;12:e007598. https://doi.org/10.1161/CIRCEP.119.007598 218. Moula AI, Parrini I, Tetta C, Lucà F, Parise G, Rao CM, et al. Obstructive sleep apnea and atrial fibrillation. J Clin Med 2022;11:1242. https://doi.org/10.3390/jcm11051242 219. Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 2017;13: 479–504. https://doi.org/10.5664/jcsm.6506 220. Linz D, Brooks AG, Elliott AD, Nalliah CJ, Hendriks JML, Middeldorp ME, et al. Variability of sleep apnea severity and risk of atrial fibrillation: the VARIOSA-AF study. JACC Clin Electrophysiol 2019;5:692–701. https://doi.org/10.1016/j.jacep.2019.03.005 221. Linz D, Linz B, Dobrev D, Baumert M, Hendriks JM, Pepin JL, et al. Personalized management of sleep apnea in patients with atrial fibrillation: an interdisciplinary and translational challenge. Int J Cardiol Heart Vasc 2021;35:100843. https://doi.org/10.1016/j. ijcha.2021.100843. 222. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107:2589–94. https://doi.org/10.1161/01.CIR.0000068337.25994.21 223. Abumuamar AM, Newman D, Dorian P, Shapiro CM. Cardiac effects of CPAP treatment in patients with obstructive sleep apnea and atrial fibrillation. J Interv Card Electrophysiol 2019;54:289–97. https://doi.org/10.1007/s10840-018-0482-4 224. Mittal S, Golombeck D, Pimienta J. Sleep apnoea and AF: where do we stand? Practical advice for clinicians. Arrhythm Electrophysiol Rev 2021;10:140–6. https://doi.org/10. 15420/aer.2021.05 225. Hunt TE, Traaen GM, Aakeroy L, Bendz C, Overland B, Akre H, et al. Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: a randomized controlled trial. Heart Rhythm 2022;19:1433–41. https://doi.org/10.1016/j.hrthm.2022.06.016 226. Caples SM, Mansukhani MP, Friedman PA, Somers VK. The impact of continuous positive airway pressure treatment on the recurrence of atrial fibrillation post cardioversion: a randomized controlled trial. Int J Cardiol 2019;278:133–6. https://doi.org/10. 1016/j.ijcard.2018.11.100 227. Labarca G, Dreyse J, Drake L, Jorquera J, Barbe F. Efficacy of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea: systematic review and meta-analysis. Sleep Med Rev 2020;52:101312. https://doi.org/10.1016/j.smrv.2020.101312 228. Abuzaid AS, Al Ashry HS, Elbadawi A, Ld H, Saad M, Elgendy IY, et al. Meta-analysis of cardiovascular outcomes with continuous positive airway pressure therapy in patients with obstructive sleep apnea. Am J Cardiol 2017;120:693–9. https://doi.org/10.1016/j. amjcard.2017.05.042 229. Yu J, Zhou Z, McEvoy RD, Anderson CS, Rodgers A, Perkovic V, et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA 2017;318:156–66. https://doi.org/10. 1001/jama.2017.7967 230. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016;375:919–31. https://doi.org/10.1056/NEJMoa1606599 231. Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Albertsen IE, Lane DA, et al. Alcohol intake and prognosis of atrial fibrillation. Heart 2013;99:1093–9. https://doi.org/10. 1136/heartjnl-2013-304036 232. Lim C, Kim T-H, Yu HT, Lee S-R, Cha M-J, Lee J-M, et al. Effect of alcohol consumption on the risk of adverse events in atrial fibrillation: from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) registry. EP Europace 2021;23:548–56. https://doi.org/10.1093/europace/euaa340 233. Lee SR, Choi EK, Jung JH, Han KD, Oh S, Lip GYH. Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study. Eur Heart J 2021;42:4759–68. https://doi.org/10.1093/eurheartj/ehab315 234. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093–100. https://doi.org/10.1378/ chest.10-0134 235. Takahashi Y, Nitta J, Kobori A, Sakamoto Y, Nagata Y, Tanimoto K, et al. Alcohol consumption reduction and clinical outcomes of catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 2021;14:e009770. https://doi.org/10.1161/CIRCEP.121. 009770 236. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm cohort of atrial fibrillation. Eur Heart J 2010;31:967–75. https:// doi.org/10.1093/eurheartj/ehn599 237. Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, et al. Pattern of atrial fibrillation and risk of outcomes: the Loire valley atrial fibrillation project. Int J Cardiol 2013;167:2682–7. https://doi.org/10.1016/j.ijcard.2012.06.118 238. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22:983–8. https://doi.org/10.1161/01.STR. 22.8.983 ESC Guidelines 3389 Downloaded from academic.oup.com/eurheartj/article/45/36/3314/7738779 by guest on 07 October 2026